drugset / Trial / NCT02968719
A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®
RandomizedCrossoverOpen-labelTreatment
Summary
A Phase 1, Randomized, Open-Label, 3-Way Crossover, Pilot, Pharmacokinetic Study to Evaluate the Steady State Pharmacokinetics of a Once-Weekly Application of Corplex Donepezil Transdermal Delivery System (TDS) Compared to Daily Oral Administration of Aricept in Healthy Adult Subjects
Timeline
- Start
- 2016-11
- Primary completion
- 2017-07-11
- Completion
- 2017-07-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 5 mg | Other |
| Subject | Donepezil | Small molecule | 10 mg | Other |
| Subject | Donepezil | Small molecule | 10 mg | Oral |